Please use this identifier to cite or link to this item:
Title: Cysteine and Folate metabolism are targetable vulnerabilities of metastatic colorectal cancer
Author: Tarragó-Celada, Josep
Foguet Coll, Carles
Tarrado Castellarnau, Míriam Neus
Marín Martínez, Silvia
Hernández-Alias, Xavier
Perarnau, Jordi
Morrish, Fionnuala
Hockenbery, David
Gomis i Cabré, Roger
Ruppin, Eytan
Yuneva, Mariia
Atauri Carulla, Ramón de
Cascante i Serratosa, Marta
Keywords: Càncer colorectal
Colorectal cancer
Issue Date: 23-Jan-2021
Publisher: MDPI
Abstract: With most cancer-related deaths resulting from metastasis, the development of new therapeutic approaches against metastatic colorectal cancer (mCRC) is essential to increasing patient survival. The metabolic adaptations that support mCRC remain undefined and their elucidation is crucial to identify potential therapeutic targets. Here, we employed a strategy for the rational identification of targetable metabolic vulnerabilities. This strategy involved first a thorough metabolic characterisation of same-patient-derived cell lines from primary colon adenocarcinoma (SW480), its lymph node metastasis (SW620) and a liver metastatic derivative (SW620-LiM2), and second, using a novel multi-omics integration workflow, identification of metabolic vulnerabilities specific to the metastatic cell lines. We discovered that the metastatic cell lines are selectively vulnerable to the inhibition of cystine import and folate metabolism, two key pathways in redox homeostasis. Specifically, we identified the system xCT and MTHFD1 genes as potential therapeutic targets, both individually and combined, for combating mCRC.
Note: Reproducció del document publicat a:
It is part of: Cancers, 2021, vol. 13, num. 3, p. 425
Related resource:
ISSN: 2072-6694
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Files in This Item:
File Description SizeFormat 
707377.pdf3.86 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons